Two private equity-backed Chinese companies – Rundong Automobile Group and Luye Pharma Group – are reportedly planning to raise a total of $1.5 billion through Hong Kong listings.
Greater China | 10 Feb 2014 |
Navis Capital Partners has acquired a controlling interest in Amazon Papyrus Chemicals Group, a Hong Kong-based chemicals manufacturer that supplies the paper and pulp industry.
Buyouts | 30 Jan 2014 |
Yunfeng Capital and Alibaba Group together plan to buy a 54.3% stake in pharmaceutical data provider CITIC 21CN, a Hong Kong-listed subsidiary of Chinese conglomerate CITIC Group, for HK$1.33 billion ($171 million).
Greater China | 24 Jan 2014 |
Hamilton Lane has added two senior professionals to its Asia team, appointing Mingchen Xia as principal on the fund investment team and Yen Li Chew as vice president within its business development group - both will be based in Hong Kong.
People | 21 Jan 2014 |
AAB Group, a Chinese diaper maker backed by RRJ Capital, is said to be looking to raise as much as $300 million through an IPO on the Hong Kong Stock Exchange.
Greater China | 20 Jan 2014 |
GIC Private has exited its 8.84% stake in Beijing Capital International Airport (BCIA)to NWS Holdings, an Chinese infrastructure conglomerate controlled by Hong Kong billionaire Cheng Yu-Tung, for about HK$2.36 billion ($304 million).
Greater China | 18 Dec 2013 |
Artgo Mining Holdings, a Chinese marble producer and distributor which is backed by The Carlyle Group, intends to raise up to HK$1.01 billion ($130 million) through an IPO in Hong Kong.
Greater China | 17 Dec 2013 |
Consun Pharmaceutical Group, a Chinese medicine retailer backed by Hony Capital, is seeking to raise up to HK$1.09 billion ($140 million) through an IPO in Hong Kong.
Greater China | 11 Dec 2013 |
Asia-focused Hillhouse Capital will commit about HK$274 million ($35 million) as a cornerstone investor in China Conch Venture’s HK$3.59 billion Hong Kong IPO.
Greater China | 11 Dec 2013 |
“When AIFMD came out in draft form a couple of years ago we engaged the Hong Kong government to participate in the process of seeking comment,” David Pierce, a partner at FLAG Squadron Asia and until recently non-executive chairman of the Hong Kong...
Regulation | 11 Dec 2013
The Carlyle Group and Farallon Capital Management will commit $35 million as cornerstone investors in Fu Shou Yuan International’s $215 million Hong Kong IPO.
Greater China | 09 Dec 2013 |
Hong Kong-based Horizon Ventures has led a $15.2 million Series B round for Misfit Wearables, the US start-up behind the physical activity monitor Shine. Existing investors – which include Founders Fund, Khosla Ventures, Norwest Venture Partners, OATV,...
Technology | 09 Dec 2013 |
In 2010 Japan Home Centre was already a successful domestic brand but to realize its IPO ambitions it needed the right partner to guide it through a period of rapid expansion – EQT Partners
Consumer | 04 Dec 2013 |
Jintian Pharmaceutical Group, a Chinese pharmaceutical retailer and distributor backed by CVC Capital Partners and SEAVI Advent Private Equity, is seeking to raise as much as $273 million through an IPO in Hong Kong.
Greater China | 28 Nov 2013 |
Updating your subscription status
In 2015, China is expected to experience a "new normal of growth". For private equity investors, China's new stage of growth represents huge opportunities: an increase of 270% in online consumption, the reform of over a hundred sovereign-owned enterprises, trillion-dollar investments into overseas infrastructure projects, the rising entrance of young entrepreneurs, and many more.
To be held on 28 and 29 May, the 14th annual AVCJ China Forum 2015 in Beijing will feature these exciting topics and bring together top-notch speakers from across the world.Join the premium industrial gathering of over 300 private equity professionals, regulators and senior executives for two days of mind-provoking discussions, networking and more.
28-29 May 2015, China World Summit Wing,Beijing
There is a feeling that now is a shrewd time to invest in Japan and take advantage of the favourable conditions for private equity. Valuations are low compared with the rest of Asia and strategic buyers and the IPO market are providing an attractive route for exits. There are also signs that corporate Japan is slowly coming around to engaging PE as a potential buyer for non-core assets and recent developments at the GPIF suggest that PE will be under strong consideration for allocations from pension funds in the near future as well as regional banks committing to the asset class right now.
The macro concerns that have been present for many years still remain in terms of low growth and currency depreciation but these are encouraging times for fund managers looking to both raise capital from Japanese LPs and make investments.
245-26 June 2015, Conrad Hotel, Tokyo